[A group study on prognosis of ovarian cancer in Japan].
[A group study on prognosis of ovarian cancer in Japan].
复制标题
日本卵巢癌预后的团体研究。
DOI：
--
复制
发表时间：
1992
期刊：
影响因子：
--
通讯作者：
M. Yakushiji
中科院分区：
文献类型：
--
作者：
T. Sugawa;N. Umesaki;A. Yajima;S. Satoh;Y. Terashima;K. Ochiai;Y. Tomoda;T. Kanoh;K. Noda;M. Yakushiji
与22个研究所合作，对1980年1月至1987年12月期间收治的1185例卵巢癌患者进行了评估。结果是：（1）初诊临床分期分布中，Ⅲ期病例最多，其次是Ⅰ期病例，按组织学类型分类，浆液性囊腺癌以Ⅲ期最多见，在III期和IV期观察到未分化和未分类的癌。 (2)在预后因素的检查中，证实临床分期、组织学类型和初次手术后残留肿瘤的直径是重要因素。 (3)组织形态学分化程度与预后存在显着差异，这种差异主要是由于各分化组临床分期分布存在偏差。 (4)患者年龄的预后呈现向年轻化的良好趋势。 (5)当考虑治疗的开始时间时，已看到逐年改善的趋势，并且认为CDDP化疗的有益效果对此有所贡献。
An assessment has been made, with the cooperation of 22 institutes, of 1,185 cases of ovarian cancer as subjects who were treated in the period from January, 1980, to December, 1987. As a result, (1) As for distribution by clinical staging at the initial examination, the cases in Stage III were the most numerous, followed by those in Stage I, and if classified according to the histological type, serous cystadenocarcinoma was the most frequently observed in Stage III, and undifferentiated and unclassified carcinomata were observed in Stages III and IV. (2) In the examination of prognostic factors, it was confirmed that the clinical stage, histological type and diameter of the remaining tumor after the initial operation were important factors. (3) A significant difference was observed between the grade of histomorphological differentiation and prognosis, the difference was chiefly due to the deviated distribution of clinical staging in each group of differentiation. (4) A favorable trend was observed in the prognosis by patient's age toward the younger layer. (5) When the starting time of the therapy is considered, a trend toward improvement has been seen year by year, and it is considered that the beneficial effect of chemotherapy with CDDP contributes to this.